DeSci Office Hours

Recorded: July 21, 2025 Duration: 1:05:24
Space Recording

Short Summary

In a recent discussion, key players in the decentralized science (DeSci) ecosystem explored innovative strategies for community engagement, project launches, and the importance of user-centered design in driving growth. They highlighted successful partnerships, fundraising models, and the challenges faced by tokens like VITA in maintaining investor interest.

Full Transcription

hey guys GM GM uh welcome to DCI Office R run by modeler I'm Kiho and the mic
um uh we're gonna chat with uh our buddy Harlan and uh if you guys are regulars to
these officers you know what this event is otherwise just a brief intro we're gonna do some
um you know interesting takes on current dsci ecosystem and discuss those uh first principles
of dsci and and try to get a um you know sort of a a fireside chat uh with uh with the scientist
and the d scientists here hi car here. Hi, Carlin.
What's going on?
What's going on, Kehoe?
Yeah, like you said, I'm Carlin.
I'm the resident scientist coming to you live from Chicago today.
I'm doing some research at Northwestern to finish my PhD.
You know, and really excited to talk about, you know,
where DSI is evolving and where we think it can improve.
We're always looking to constructively criticize
how we think the DSI space is going.
And so, you know, how are things going with you, Kiyo?
I'm good, man. I'm good.
Yeah, I'm reporting from south of india um summer weather half past
eight uh yeah quite uh yeah quite windy but but i really enjoy this uh nice breeze
and today we have something interesting to discuss as always and carlin do you want to
set up the stage yeah so i'll talk about it a little bit i have recently been reading a very
interesting book called building backwards to biotech the subtitle being The Power of Entrepreneurship to Drive Cutting-Edge Science to Market by Stephanie A. Wisner, W-I-S-N-E-R.
It's been a really interesting read.
As a scientist myself, I think that a lot of our thought processes go from what is the problem, What are the existing or the, you know, the lasting
issues with the current solutions to that problem? And then, you know, what is the science that could
potentially lead to this new innovation? But this book kind of posits that, you know, in our thinking,
we really need to focus our like final thoughts, as opposed to, you know, a general, like, oh, I want to one day
cure such and such disease. Instead, you need to look for places in the market where there's,
you know, a true lack and where a place where customers and, you know, potential patients and
doctors think, oh, there is not enough of a, you know, of a solution here to then make sure that all of your actions
lead in a like stepwise manner toward achieving that goal which I when I as I'm reading I'm like
thinking of D-Sci and I think about you know maybe like a DAO that has a little bit more of
like a general goal but doesn't necessarily have the you know final product in their head of what they're going
to be but yeah it's been really interesting um yeah i i also had like uh an opportunity to to
just dig into like what this book is about uh but didn't really really go through it completely something that was interesting for me was
this idea of user-centered design oh yeah i think i think that is something
struck directly with the the concept of design right ideally building things that matter for
the citizens and the people you know whom really whom who really interact with the
science as a commodity um so yeah i would like to dig a little more into the aspect of user-centered
design from the current dsai ecosystem perspective um do you think uh the sort of model is existing or practiced in current existing DAOs
because the real potential of the DAO or a community
is basically the members of the community, the users, right?
So the people.
But are these DAOs, are these projects in the DeSci ecosystem
using it to its fullest potential?
You know, I will say that I think that there are probably some that are,
but those that are, I think, what can be considered like some of the first DAOs,
like maybe they're not.
Because I feel like, you know, when you're smaller,
the community has more of a, you know, this like amplification effect when you, you know, not lost sight, but maybe they're not asking
the right, you know, people, the right customers, the right like level of, you know, the level of
people who can benefit from what they're trying to accomplish. I think one, I always bring up
Kirtopia, the rare disease DAO. I think that they have a great, they're doing a great job of making sure
that patients are centered. It's one thing to, I think, center, you know, your community of like
investors and stuff like that, but to also, you know, make sure that you're reaching to the people
that will actually use and benefit your end, you know, your end product goal is talking to the right group of people.
But what about you, Kyo?
Any examples maybe you can think of people who are doing it right,
maybe who's doing it wrong?
Yeah, like on top of my mind, I have Qtopia, which is a very good example.
And then I think SciDAO has a very good
citizen focus.
basically they work with
their community members. I say it's
one of the most
active community where
people really go in and
help with all these sort of
functional molecule development
and sharing their, you know, experiences with these derivatives of functional compounds.
Yeah, I think Syda when I said Qtopia is also like they're doing a great job in this,
but I think we need more of this, right?
more of this yeah right like more of community driven projects because uh i think the community
Like more of community driven projects,
is one of the the clear usb as say like for the dows or like any sort of the dsai movement
um it's it's based on the community movement and then like loosely also based on the scientific
focus that you you take up as a challenge right right? And basically that science focus really brings that community around this,
the focus group.
And then once you bring the community,
the idea is to, you know, use them to build the products, right?
And use them to really test the products and also use them,
also like let them use the product, right?
So I would see it as a see it in
this way where you and i have let's say a problem of you know some some rare disease or some functional
metabolic diseases then probably for us what is interesting is to find solution that matters to
us and find solutions that work for us right and also to and
and using that you know as the power of the community uh dao could really use the community
incentivize the community to to test build and launch the product and ideally them being the as well right and yeah i think i think this this is is how we need to pitch dsai because if you
look at any startups what they crave for is community a loyal community to their product
right like a loyal user base right but in in dows you already have users. You just need to make use of them to build the product that really matters to them.
And it could be a product of scale or it could be a product that just, you know, like aligns with those users who are interested to use it.
It doesn't have to really appeal for the whole world.
But if they really enjoy and their testimonials are gonna fly in and uh that's
what will attract more people towards the product i think that should be more sort of a cornerstone
or like the top 10 objectives or the other or the way to go for dows but i also understand right like
some projects uh are each projects are different.
It's really difficult to get that, you know,
into every project. But then a follow up question or something to,
you know, ponder upon.
So now let's say we have this, you know,
user-centered development adopted by a bunch of the DAOs.
How do you think this could create more sort of skin in the game for the users to come in and contribute,
not just being mere product testers, but rather people who actively are contributing to that IP and building that IP forward?
actively are contributing to that IP and building that IP forward.
How do you think this could shape up in the future for those contributors who come in,
in terms of it could be rewards, incentives, or like, you know, a share or stake in the IP?
It could be a lot more different things.
Do you have any sort of ideas around that, how we could implement this?
I think that's a really interesting way to go about it.
And I think that probably for, you know, speaking, if I were one of those people in those groups,
I think that I would want, you know, what everybody I think is looking for is, you know, a little bit of a say. They want
to have like a, you know, a role in the ultimate decision making. And I think that currently
a lot of the ways that DAOs do it are by like their contributor working groups.
But who's to say that, you know, these working groups and like, you know, the general deal flow or whatever doesn't spin off into its own specific, like, let's say there's like an IPT, like you're, you know, you're a DAO who, you know, work to create a, your end goal as the DAO is, you know, let's use SpineDout as an example. I've been thinking about them a lot recently too.
Your end goal is to make, you know, spine care better for both doctors and patients.
And there's many, many different ways you can go about that. And so maybe you're,
as a contributor, you're like, oh, what I would like to see is this. So your specific, you know,
survey feedback is the avenue through which they started working on a specific aspect of the problem.
And then from that, maybe they can, you know, working backwards can be like, okay, if you are one of the people who voted for this to be the biggest issue that, you know, led to this successful end product, then maybe you are
the now you have, you know, say in that IP, you have, you know, a little bit of ownership, maybe
you have a, there's a specific, you know, maybe for earlier DAOs, when there's not necessarily
this like constant cash flow coming back in, you can maybe have like a more specific
reward program, like you were saying. So maybe, you know, you get a, if we're, if we're super
rich, you get a Bitcoin. If you contribute to an idea that ends up being like, you know,
achieving, you know, different milestones too, because these different, you know, things can
go through, you know, international patent processes, you know, different decentralized methods, these sort of things.
So that's, you know, a long winded way of saying rewards are the way. And if you, you know,
start to work back toward the feedback, and then use that as the method of, you know, sort of like
actually doing the community drivendriven part of everything,
I think that that can lead to a more rewarding, incentivized sort of way to go about it for the actual contributors
so that they're going to want to keep contributing.
Yeah, yeah, I completely agree with that.
that and yeah just something came to my mind we also had something sort of this discussion within
And yeah, just something came to my mind.
within the DAO within the microbound DAO and all and some some of the other DAOs as well in in these
spaces where you know for for some of the DAOs data data could be an interesting contribution to the DAO or to the knowledge repository or whatever that the DAO is building.
So we thought if you would start to incentivize people or reward people for the data that they contribute, how this could happen?
Because there are a lot of attack vectors.
Things could get gamed uh quick and it's really hard to uh control it in a way that you know people will then start
to fabricate uh you know data just order to harvest these tokens or rewards right so there
are a bunch of attack vectors as well and then we started digging into it closer and closer,
different ways to kind of streamline the data contributions.
And we came up with the method,
just something like how Bitcoin works,
where you need to mine things out of it and there's also an
halving effort effect so when you are early to this project you get like bunch of
uh token rewards as you contribute but then as as things go further and further as you are
staying there for the long time um the the incentive levels actually go down um the idea is
um is to also like protect from these different attack vectors and also to control the the rewards
that could happen uh and also to to find differentiate what is good data and what is bad data
and all of that so we we came with some some models to to really test this but then
we didn't really get a lot of interest from the community we wanted to implement this we wanted
we did a survey we didn't get like you know feedbacks on like how this could happen or like whether people are interested in such solution.
And I think we were asking a different set of audience.
Which is a very small Venn diagram because I'm looking at people in crypto and people who have that health issue within that crypto circle.
And that intersection of that Venn diagram is very small.
So probably, I think, going forward with all these user surveys
or user-centered design is also important to either onboard those crypto folks
to a particular use case that you are solving,
or else onboard Web2 folks to particular use case that you are solving or else onboard web 2 folks to to come and
you know join and actively engage with your project so it has to be either way you need to
build bridges into the web 3 community and also into the web 2 community and this will then
actually will help you to to really see whether there is an interest or whether this sort of contribution
model works because as you said like it is easier for uh curtopia to do something like that because
it's basically a community uh spin-off i would say there was an existing community yeah of rare
disease people and their families uh who were looking actively for those solutions and then they found this DAO
and then it could be just easier from there right but then like for projects that
coming from top to down where you take up an issue and then you try to form the community
and all of that it really gets a becomes a very tedious task to really implement this
becomes a very tedious task to really implement this. I just want to take this
into a different direction into our existing IP tokens as well, right?
Because each IPT is again then communities who either invested for that
projects, you know, whatever IP that the project promised or they could be just looking for the next dsci
token or the collections yeah collecting gems yeah so yeah exactly we have different sort of
uh community one into the web 3 and the other into the web 2 who one comes for real value and
all of that the other comes for speculation aspect of it or the financial aspect
of it but then uh this conversation i would i would like it you know to to enter into that realm
of figuring out how we can keep these communities engaged through that line of through that process of user-centered development if we if we
agree to do it that way how are we going to keep that users engaged through that development process
because that is one of the biggest issues right like the concept is good the model is good you
can test it the theory theoretical part of you, doing something like that is very interesting.
But even when you have a community, it's hard when you start to execute it, right?
To get people aligned and all of that.
Because, you know, at the end of the day, it's like, who cares, right?
Even if you care, it's like, well, who cares?
And I'm thinking about, I think, you know,
maybe ways that we can maybe reach these communities better is in the like the surveys and stuff like that.
You know, I don't know if you have it on hand, but maybe some of the questions that you asked might have been, you know, not necessarily leading.
But sometimes when we make things like this, I think we go in with preconceived ideas of what people might want or
what might be good ideas. But I think that one thing that I've learned from reading this,
the Building Backwards book, is that going in and doing sort of like, you know, the customer
development side of things without letting people know what you're trying to find out
is a great way to actually get the like
root of a lot of these problems. So like, you know, sending out like a community survey and
being like, you know, what is a good, what is a, a good community to look like to you or something
like that. And then, you know, taking those things into account as you're, you know, adjusting and
building for the new, for both, you know, people who are coming from a Web2 side, who, you know,
maybe have a more traditional, like, forum, you know, based way of like, going about things like
a question or response sort of thing, versus the, you know, the more the Web3 crypto people who are,
their community is a like constant, like stream essentially, like 24 seven, if they, if they want
it that way, they check in, they check out sort of thing. So, you know, I think reaching people
and getting their real thoughts is tough, but I think that that's going to be the way
to actually get people to stay engaged.
And I think you do that through getting them to tell you
what they actually want to see
without them figuring out what you want to hear.
Because I think I'm one of these people,
I want to tell people what they want to hear.
I am a people pleaser.
Not unashamed for that.
But, you know, I think that for the problems that Desai is trying to fix, it takes, you know, the unafraid, you know, being out there, you know,
being a maybe anonymous server user, but, you know, guarantee that you're a member of the community, so you mean well sort of thing.
But yeah, I think that it's definitely a difficult issue, but maybe through better hypothesis-driven outreach, we can grab people in a more like authentic way
okay so then uh let me propose an hypothesis that i would like let's consider a small experiment
that i would be you know i would propose for us to test you know for example uh look at this ipt allocations for any ipnft projects right
um so there are a bunch of tokens allocated to the dao and then then bunch of tokens allocated
to the funding community like could be retail investors who funds the dao what's the ipt right
can we create more skin in the game for all these different parties involved because there is also
a bunch of allocation going to the inventor slash scientist can we do that also for the patients
right or the community members who are then have who then have like vested interest to test the product or test the IP are part of what the IP is trying to solve, right?
A part of the problem.
Let's take example for Hempi, the project that's building those, you know, affordable or sorry, functional fabrics out of hemp fibers, right?
of hemp fibers right so it could be textile manufacturers or people who use clean products
uh people who promote hemp uh or who are who are like you know these climate friendly uh people
who just don't want to you know uh use um other fabrics or goods so So then for these people, we could then create more skin in the game
if they would come in, fill in the survey
or fill in some information
that could be part of the product development
or the IP development.
Then they should also be able to mine some IPTs, right?
This allocation could come out of the DAOs
or we could, or early on allocate some of the funds for
these sort of activities. Yeah, like a discovery type of allocation or something like that.
Exactly. Let's say having 5% of the total IPTs allocated for this sort of discovery or the user
surveys or even data contributions. Let's you you use our product as a textile manufacturer
or try it in your manufacturing pipeline and see like if you come back with comments and you know
suggestions and feedbacks then you get like some allocations or like you can mine some
ipt's out of it really building that skin in the game if you once become the ipt holder like the the
the token holder of the ips then probably you
will have you know how can i improve this because if if this thing improves if the ip
is improving better then i have a better way to exit out of this right yeah yeah your position
continues to improve exactly i get a bigger exit right yeah so i think this could be
this is something that i'm suggesting like one of the hypotheses but this cannot be done for any sort
of traditional science projects where it's really hard to gauge and understand who are the real
uh users yeah from 10 years from now yeah but then we will definitely have some people who have vested interest coming there for that science.
Or we could take a simple product-driven app
or real consumer product IPTs like MP
or Nextin Amphithogens or even Claw,
which is a supplement, right?
So we could then pick up some of these projects and
people who are trying those supplements and giving you know citizen science feedbacks to
to really reinforce that product and back that product with data right which would then boost
the sales of the data having a data provenance chain around it, having a bunch of, you know, data points backing the products,
whatever, like speaking
of its merits or advantages,
disadvantages, whatever.
What do you think of this model?
Should we try and test this
in some of the upcoming projects?
We should definitely try to test it.
But I'm worried, what if,
what happens when the data is negative? You know what I'm worried. What happens when the data is negative?
You know what I'm saying?
What happens when people are putting all this effort and all these incentives toward a project?
And then it's like, oh, well, it didn't work the way we thought it would.
What happens then, do you think?
That's why we need to define clearly how these contributions are going to look.
How these rewards are going to take place.
Will it be right after you click the button, submit data, or is it after, you know, it gets really assimilated into the process of building that IP.
Yeah, but also keeping it balanced because then if it's too complex or too, you know, there's too much of a wait time between contribution and and uh reward people will
not be as incentivized to do it exactly exactly probably like a a 30-day period to really evaluate
your data or like whether whether the the dev team decides this data is usable or not usable
or they can could could they can clearly define terms how this data should look,
or like what they are expecting in terms.
This could be like a user survey as well, right?
Like if you fill in valid information for the user survey,
then probably like doing three of these user survey
can give you an IP token.
Yeah, I like that too.
We could even do a survey for uh how long you think
it should be between uh contribution and reward even though i exactly i don't know why anybody
would say anything but instantaneous but if you if you're someone who you know is a good contributor
and you see you know the good and other people as well though you you then are like you know i think
there should be a little bit of a wait time because I trust that the, you know, the organization is doing the right thing in the meantime to make sure that everybody gets what they're owed sort of thing.
I like this.
I like this idea.
Agent of the Week survey agent.
It concatenates all of our survey ideas as we come up with them and sends
them out to our communities. Who's building it? I love it. I would love to build this. I would
love to be part of this. Have you heard about this coordination agent? No, I haven't.
Bonfires? No, I haven't. Bonfires. No, it's quite interesting.
I think it is from DeciWorld.
I've been looking at this. So they kind of put forth the idea that, you know, let's not look at science as just biotech, but science as something that disseminates knowledge.
So, which is broader.
It can be any scientific field. It could be citizen science or anything that disseminates knowledge so uh which is broader it can be any scientific field it could be citizen
science or anything that disseminates knowledge and the knowledge being getting assimilated and
and being like something being used out of this right so they are building agents which would
then go into your telegram chat look at what people are talking about or interesting things that people have discussed or it could be within
the the IPT token holders or the whole team of DAO IPT holders devs and you know members it's
just like the whole goal is to remember the conversations that you make and also like help
you coordinate the best also bringing that touch of uh humanness
and all of that into it i love that i'm uh gonna add that to my uh to my pump science chat if it's
if it's available yeah i think yeah i i think you should you should reach out to them and see how can you get this added.
Yeah, I will.
I'm quite interested to test this.
What's their at?
They call it lighting of the dark forest.
It's just like a three-body problem, the dark forest theory.
Yeah. Wow. Yeah, i'm sold on this they just got to follow for me awesome all right uh yeah coming back to that um ipte this yeah
yeah our experiment now we have now we have an hypothesis to test yeah yeah we do um i'm i'm
definitely willing to put some effort to you
know test whether this would work because let's let's be honest right like the the whole uh the
whole notion of uh dsai or the funding angle of dsai you know uh helping fund projects um is
still unclear like what works and what doesn't work is it like long-term big like like big reward
long wait high risky ips is of interest or is it more towards the agents or it's more toward like
consumer products what is it exactly like you know what, what works or what is of interest? I think with current approach that Bio XYZ is taking,
I heard that they are going to launch this multi-asset, you know, portfolio.
Are you dropping fresh alpha right now?
It's just like, you know, looking at what they are announcing, right?
Like they have cows in their website.
They have bio agents in their website.
Probably then, you know, like you can just go there to bio and then start funding, you know, anything that is of interest to you within the science.
Covers it all.
The DCI ecosystem.
So, yeah, I uh i'm really excited i'm waiting for it to you know really uh materialize and launch and i have
my own uh set of projects and dows that i'm interested in uh looking at what they have put
up in their website um yeah let's see let's say uh how this is gonna go but then all these problems
still remain which is that we have sent bunch of signals uh into the dark forest of uh the crypto
market but you haven't received enough signals to really measure like what really works right is it a team is it the the science yeah the idea
yeah and and and I have another question to you this is something that came out
of I think like one of the community members I was talking to um he was asking me like looking at vita dao uh vita dao is is quite
successful uh there are a bunch of new things happening i think uh the one billion dollar
deal with roche and the gero the spin-off of vita uh is interesting and then they are going to i
i think they're uh they they just posted they are launching a clinical trial soon for vita fast
i guess yeah yeah so exactly with with all of this happening i would expect vita dow the vita
token price to go up okay in general that's what the assumption is right like yeah if all these
portfolio projects works really well uh then the vita should really go up but why do you think
this is not happening is it so my my understanding is it because you have the sort of diversified
ip portfolio within vita dao where people are more interested into you know buying governance into those uh ipt's which are the ips which they
really like or uh or people are not you know going towards this meta governance token which is the
visa token um how could you see this like you know um it could be both ways right like people might
be interested in only few of the projects not, not the whole, the DAO project.
Do you have any insights or like, you know, have you been observing this?
Yeah, would like to pick up your mind on this.
So I've been thinking about this recently too, because I am not a big investor, but I want to get into more more investing.
And so when you're investing, one thing I've learned is that you have to think about your mitigating as much risk as possible.
uh since there is this sort of like accessibility to any of these IPT tokens people are kind of like
biding their time and waiting to um get in on you know they want they want to get in at low point
right so in order to actually you know come off a gain or come up with a gain but I think that with
the more like I think that IPTs are inherently a little more volatile than, like, the main, like, main token of these DAOs, like Vita.
At least that's what I would intuit.
I haven't done any, like, major calculations, of course.
of course. But I think that maybe people are, the most interesting thing is to see a project
that you're excited about and has the most likelihood to be successful at whatever its
latest sort of milestone that it's going to be is. And so people are maybe more drawn to that than as to maybe, you know, the non-thrill seekers that are just buying the, you know, the namesake token or like the, you know, if you want things to go up, buy Bitcoin or whatever, you know what I'm saying?
But if you're interested in taking a risky bet, I think that maybe you would be more inclined to go toward the IPTs.
I think that maybe you would be more inclined to go toward the IPTs.
Yeah, I think that makes sense to an extent.
But I also think the issue is probably with IPTs, you might see a token exit because then you have a clarity in the mind okay if the IP matures probably I'm
gonna get early access to the drug that's been discovered or a dividend in the sales right
whatever right now it's just governance but I have I can see what could be the exit of course
I don't know for now it's just governance rights but then I have in mind see what could be the exit. Of course, I don't know for now.
It's just governance, right?
But then I have in mind, okay, this could be the exit.
But for VITA, it's really hard to, for any sort of meta DAO token, right?
Like the governance token, not just for VITA, but like general meta governance token.
I don't really, I think this could be the confusion, right?
Like people not knowing what could be the exit or not even that. Like what is the utility other than governance?
Can I use my Vita to access some of their products or, you know,
exchange to some of the IPTs, right?
Once this happens.
So these sort of utility is something that i see is uh
is missing or or could like lead to the confusion right uh of what could be the case for
the current trend uh yeah i'm just trying to observe like different perspectives. You do definitely almost want like the micro micro transaction of it all.
Because if you if you think about like a more traditional pharma company or something like that, you would, you know, driving the value of that stock either up or for the dows because you know one one
ipt project may may uh sunrise and sunset but that doesn't necessarily mean that beta itself is you
know um the they're able to sort of like you know they can cut ties or sever that sever that head
without losing any um you know any traction, I think, in their space.
But at the same time, it's not as sure from a day-to-day.
I think those are more affected by the general market conditions
than the more near-catalyst type of projects.
But that's just kind of my point of view on it
yeah i think i think it it has a lot to do with the market uh not with the the project itself
but i think there is also a mixed signal as well right like it could not be just the product like
if the other things are like really improving there's a lot of uh you know data downloads coming
up and a lot of new deals happening um i'm just trying to observe it as well but um yeah like
coming back to your point um you said it's uh like you know not necessarily like mimicking the the real biotech uh share model where you
buy shares and you see like if anything goes up in that particular uh you know company then
your share price goes up do you suggest like in a hypothetical scenario would you suggest
upcoming dows to just use one token for everything?
You know, damn near. I'm like, I mean, in my head, for my money, they should all just use bio.
But, you know, I think it's, I don't know.
Because at the same time, you know, you don't want to fall into the same traps of the traditional again and again again sort of thing.
You want to keep what makes D-Site great, which is that it is, you know, it's flexible, it's modular.
It's modular. You can, you know, take out what you like and leave what you don't.
You can, you know, take out what you like and leave what you don't.
So I think maybe it depends on what you're I think, again, building backwards, like it's of like flagship token and then that be your IPT that then evolves to become your sort of like company surrogate.
But if you're maybe more of an incubator type of DAO where you know that you're going to have a lot of projects, maybe then you can, you know, from the jump, use a more, you know, an already maybe already existing chain or like coin or something like that.
And then convert that into the like IPT for each of your specific projects as part of your like, you know, allocation that goes out to people.
people that then they can convert easily into something else if they want to, or they can
like stake it back in, which then, you know, leads to hopefully more innovations from your
Because I think that way, then if you're the like very specific project and you come
up on a, you know, a showstopper type of result, like either it tells you you need to go a different direction
or you need to shut this thing down entirely.
You have a lot easier way of taking the utility
and value of that token and then pivoting
to whatever your new sort of use case would then be.
I kind of agree with you. I think if you if you if I would just answer the question, I wouldn't go for one token. building more utility towards that one key token uh sort of the dow meta token uh building the
highest utility possible and attaching it or tying it uh in all possible ways to all these existing
ipt's you know yeah that would be uh that'll be my way of doing it like uh to to reinforce the dow token with uh all these ips uh all the ipt's that's
coming out of the dow and not seeing it as something that is you know uh disconnected
from the dow like because if if that connection is severed i agree like if you if you take the
incubation model of you know just incubating bunch of project expecting them to venture out
you know just incubating bunch of projects expecting them to venture out after a period of
time the the ipt model like really is the way to go forward because then you know you could then
build these asset portfolio and don't have to be bothered about you know your uh the meta governance token being stuck into all these
different projects yeah and uh tethered kind of to a you know governance exactly care about
exactly becoming a hurdle as well in the future if you want to translate it to more sort of a traditional startup. Yeah.
Yeah, I think these are like,
I really enjoyed this discussion.
Now we have, let's say, 15 minutes.
I'm going to open up the forum for our listeners here.
Guys, please feel free to hit the speaker.
Please request. I can bring you up on stage we have uh vexa here and we have uh the brand new dow which born out of uh molecule dc our office hours last
week sickle cell dow um we would like to hear from you wow Wow, so sorry I missed that last week.
I was traveling, so I, you know, could not be here.
But wow, a new DAO formed during office hours.
I love to see it.
Let's hear it from Vex.
What up, Shorty?
All right.
I sent you a request, Vex.
So, guys, please feel free forward to come up and ask your questions uh also feedbacks if possible uh leave it in the comments or like come up
uh straight away uh yeah anything you want us to talk about let us know exactly Hi, Rex.
Carlin, Jim Jim, everybody.
I don't know what's wrong with my network.
How is everyone doing?
How are you?
I'm fine, yeah.
So from the last episode we had,
you gave me a call and I think I've actually answered.
SQL cell dial is down there.
The Twitter account and the telegram is ready.
This week I'll be going to our state sickle cell clinic to onboard some doctors and nurses to the DAO.
And I'm just going to build in like right now. help like after the like questions to most of the desire enthusiasts for their contributions
in community building and etete yeah we had a call that was last week on the technical side
of the dao where um he said we should focus the focus on the community first so we could get researchers i'll be sending
emails to to researchers i've have created like a list of researchers i've had have hosted one
research on myspace she worked on um oh and how to how to um diagnose like get to know if someone is sick of self from when from bed
not just when they get old and she worked on how to like um mutate the sickle cell cell
which um what's it called amoeba since it's shapeless and it's fluid so it's good um you know the the the sickle cell cells they exist in clusters so
they don't close the joints they can maybe use since they are mutated with their moeba but she
didn't get the fun thing that was the thing and i onboarded that to umai. I sent her the Research Hub,
the Research Hub,
yeah, their website.
And I told her about Molecule Dao,
that she could do nice research
because she does lots of them.
So that's currently where we are in right now.
So I don't know, do you have any suggestion, any contribution?
Because it's a community project.
It's for all of us.
Everybody has a contribution here.
Yeah, we'll just take it step by step, and we'll see where it goes.
Because in Sikufel, that's where we believe in possibilities. Thank you so much.
Nice. Sounds like things are going great. I'm glad to see that you're doing a community first
sort of approach. I think that that's key to success in DSI.
I think that that's key to success in D-Sci.
And yeah, I'm happy to spread the word
and let anybody know that this is a movement now
so that any other helping hands
or specific types of contribution that you're looking for,
just let us know.
Thank you so much.
Thank you so much. I'm personally so happy to see to, you know,
she's already in touch with the community.
She wanted to, you know, really take this up
and build the DAO.
And I promised any sort of support that I could do
and any sort of, you know, yeah.
So feel free to, you know,
either DM me at Kehoe6RedApp personally or in any way, like, you know, if you want to help from Molecule Tech Stack in terms of launching your first IPTs or like, you know, launching your DAOs or anything.
Super happy to, you know, introduce you to people who can help you do that.
that. Yeah. And I think Karlyn will be seeing less and less of Vex in our DCI office hours
because she is now being full on in the building mode. Yeah. We'll be missing you, Vex.
We'll be missing you, Vex. We'll see you in the stars.
No, don't miss me.
I don't want you guys to miss me.
I want to.
You'll soon be too popular to even be able to hop on our little call.
I want to.
Never forget where you got your start.
I want to be here.
No, I'm Never forget where you got your start. I want to be here. No, I'm saying that.
Yeah, that's really great.
I'm really happy to hear that.
Bex, you're kind of our, I don't know, you're a great case study of just taking DSI at its value,
at what it's worth and making it something that works for you and the people that you care about.
So really, really appreciate you attending, doing all your spaces, and now building for real. It's super cool.
Thank you so much. And I have Sarah here and Diraira they've always been my go-to people actually
so it's it's a community project it's not just um everyone is building in
sickle cell doubt everyone everyone is in everyone everyone everybody's contribution is needed
everybody's contribution is needed everybody's important one person we just need one we don't
need like a hundred silent voices we need like one loud voice yeah i love that we need one loud voice
everybody talks together that's that's exactly the spirit uh that a dsci builder should have or any anyone that dsci ecosystem to have uh it's not
just about i or me it's about the collective right like it's about building the solution that matters
for the uh the comments right um super happy we'll be uh closely watching your moves and
uh supporting you in the best possible ways uh yeah keep building
to the whole community yeah
uh carlin i guess like this could be a nice initiative uh for from the dsai africa side uh
if if you wanna you know source project or if you want to
make some intros to vex in terms of scientists who could you know like really come up and
build those early steps or like some of the solutions for the foundational problems that
sickle cell daO has defined.
I think it's good to like, you know, keep this conversation going.
Yeah, absolutely. I think that that's, you know, anybody there,
I feel like there's a really strong community building in like the Desai Africa space. And so, you know, let's continue to build those bridges and, you know,
look to anybody who, you know,
knows of any infrastructure that could help out with these projects or,
you know, anybody who is a burgeoning scientist who needs a chance, you know,
these are the opportunities that we want to present people with.
So spread the word.
We got a couple of people requesting to speak.
Great, come on up.
So we have Tim on the stage. Tim, do you want to introduce yourself and go ahead
okay um yeah let's let's go with derek now tim is tim is back i think tim's ready hello
can you hear me tim yes hey uh yeah so i just had a quick question as to what exactly gets tokenized and what promotes the buy and sell of that token
so so here what gets tokenized is the access or like the governance rights to that particular
IP in speaking in the context of IP tokens so So this IP could be a future forward intellectual property
because you don't know what will happen
to that science project.
It could be, it could yield some positive results
or negative results,
but you are basically tokenizing the governance rights,
which is gonna control the direction of that particular IP,
whether to choose it to, you know, like if you want to commercialize the IP, license the IP,
or if you even want to monetize that for the IP token holders,
all sort of governance rights embedded within that.
Okay, because I'm, you know, I'm researching the projects and, you know and I read that it is the IP itself.
I'm assuming it's the physical IP, not just digital IP, right?
It's all of it.
Yes, it's the physical IP.
Any sort of immaterial and material things that's going to come out of that particular
research that the token holders
funded okay because i have some research and i definitely want to tokenize it and bring it on
onto a blockchain and the thing is uh what's yielded from the research is products themselves
so i'm having difficulty seeing the products themselves become tokenized other than a nft for example
rather than a governance token i think uh it could be a little more flexible as well like
yeah like tell me what you have uh you know specifically in your mind in terms of product and uh then we could then have like a
discussion probably uh async after this call and and and figure out uh what angles of this could
be like really tokenized um yeah but then I think if you choose to like really bring it on chain
and then I think uh tokenizing is a very good aspect.
You don't really have to tokenize the whole of the project or let's say, for example, you have you want to tokenize 20 percent of, you know, the whole tokens and then retain the rest and then do a crowd sale for that 20%. I think it is also fine. You just need to define the terms and conditions
for those token holders.
You can also define what sort of rights they could have
because we are in this realm of governance rights
because it's one of the innate,
I wouldn't say utility,
but the innate function of the token itself,
which is to you know exercise
the token to govern something uh but then you could then add a bunch of utilities on top of
these tokens if you want to uh or you could then also like you know uh do a financial dividend out
of it then it'll become securities then it's a whole new problem to sort out as well. But then it's up to the inventor and the community that's funding.
So it's quite flexible on case-by-case basis.
Yeah, I could see that going a lot of different ways,
but I'll definitely DM you a little more details. Thank you.
little more details. Thank you. Awesome. All right. We have Derek requesting to speak. because um okay yeah shout out to you guys um it's nice being here uh because molecule
carlin actually was special education that came into this space yeah shout out to the
team and a good person in the space nice being here um i know a brief like a small and a little
big and i said like 20 percent later about this site you know because i'm getting to interact
with a project on decentralized science um decipher
so um i have a couple of questions right i'm not really like grounded in this i you know
i just something i'm exploring i'm currently i'm on my medical student right yeah uh but i'm not
graduated but yeah uh i like to ask i um is that like uh because i know that you know in this i you can
launch your research you know get community funding and those research can be took nice
right your ideas and get uh fundings you get uh support right to bring your ideas to reality to
push it to the next level right um i like to ask them uh based on how a molecule is doing here right do they have like um a standard uh research or an
idea we meet right before it um gets uh tokenized right or uh maybe probably because there are some
platforms that um like i said i'm not really that i decipher you have to like um your search has to
be something that um people have not really like explored.
It should be something new and it should meet like some certain standards, right?
Before this search gets up nice.
I just want to know if that's how a molecule is or maybe you can give me a brief insight
of how your own model or infrastructure is.
infrastructure is. Thank you.
Yeah, so as like a short answer to your question, we definitely have a, you know, a certain,
you know, quote unquote standard of what sort of like projects end up getting tokenized.
What that standard is varies pretty, pretty widely. I think, you know, we have a general
like, you know, you need to make sure that you're not like pitching some legit, you know, fake pseudoscience sort of thing.
But as long as it's something that's, you know, based in, you know, real scientific literature and is a problem that isn't something that would harm people, I think in general, it's then eligible to be tokenized.
to be tokenized. But if you have an idea, you know, hit us up and we will, you know,
talk it out and see if it's, you know, something that would be
applicable for our sort of, you know, tokenization and funding mechanism. Because, you know, it might
be that it's, you know, an early idea or something, and you just need a little bit more development or
to try a couple more things before then actually coming up with
the project that ends up being tokenized. But yeah, like I said, there is a standard. We want
to make sure that we're not just putting up like, you know, bad or dangerous projects, but it is,
you know, not a super gate kept, you know, ivory tower sort of situation like a lot of institutions that we see. We want
to be broad-minded and understanding of a lot of different types of projects too.
Thank you so much. What I ask is that for me, I'm actually having some thoughts in my
mind. Although I'm not working on something, um someone that uh i'm more inclined like i love um rw is and you know i
love tech talks i'm more interested in tech right so always looking for ways to bring my vision on
chain yeah uh being on the street um for a while has been a woman for me so always like looking for
ways to bring my career on board so i'm still like uh exploring so
many things right trying to get my hands on some stuff so yeah um i'm just sure to get a flow right
in case i come up with ideas and have questions you know um definitely like reach out to you guys
um it's nice being here uh thanks for answering my question and shout out to bexalia i think uh
if i had even had no flow i shouldn't have been here so yeah thank you guys
no flow hash in time here so yeah thank you guys
thanks derek thanks derek thanks for coming up yeah please uh so anyone who is interested to
tokenize their uh projects uh please feel free to reach out uh to molecule uh yeah we'll we'll then take it from there um yeah and we are top of the hour i think like we
are six minutes past the timeline but yeah little bonus time i told you guys i i missed last week so
i needed a little extra gap time exactly yeah but then it was wonderful um having this uh office
hours and talking to you carlin ve, Vex, Derek, Tim,
who are missed this,
please feel free to come up
on the stage next time
or feel free to post your questions
as comments below.
We'll try to address them
as soon as possible.
Thanks for tuning in.
On to Carlin.
Keep building. Have a great week. and like keho said if you got
any questions you can at me directly or at molecule or at keho six right ape and you know other than
that love you hang in there bye guys have a good one. Peace.